Company environment · Targeted small molecules · clinical operations
A hospital running a cancer drug trial
In its pivotal human trial; the site is starting up. Start at the top to see what the company does, then the jobs AI models were given here and how each scored.
1What does this company do?
A large cancer hospital that runs clinical trials for drug companies.
The hospital is a trial “site”: it enrolls patients, gets ethics approval, keeps the official study files and bills correctly. The drug company sponsors the study; the hospital does the work on the ground.
2Where is the product on its way to patients?
A drug company’s pill for advanced breast cancer, in its main (pivotal) trial.
- 1Discovery
- 2Lab & animal studies
- 3Human trials
- The product is here
- 4Filing & review
- 5Approved
- 6On the market
The hospital is preparing to open the trial locally. Later, a separate job audits the site mid-trial after the study plan was amended.
3What is happening right now?
The ethics board deadline is 25 April and the sponsor’s start-up visit is 20 May.
Before any patient enrolls, the consent form, ethics submission, investigator paperwork, billing plan and study files all have to match the current study plan.
4Which jobs were the models given?
10 jobs, each graded against a specialist’s checklist.
Scores are checks passed out of checks in the list. Each model ran each job once.
5–7Evidence, work and verdict
This company’s files stay private.
It is built from a real product’s records, so its files, runs and checklists aren’t published. To follow a job all the way down to each check, open one of the public environments.
Havenor Therapeutics (fictional, fully published) →
Broad Institute (real, public FDA record) →